The article attributes it to the pace of physiologic change rather than a direct effect on the head
Not a drug, supplement, or food.
Explore it here: #GLP1 #EmployeeBenefits #TotalRewards #MetabolicHealth #HealthcareInnovation Employers rethink GLP-1 benefits with Calibrate's Defined Contribution model GLP-1s have changed obesity care
Regional skew is modest but real: current use is slightly higher in the South (17.0%) and West (17.5%) than in the Northeast (13.8%) or Midwest (15.3%), which gives field teams a coarse first pass at geographic prioritization
As previously reported, their effect on MACE goes beyond glycaemic control: the reduction of atherosclerotic plaque formation, regardless HbA1c reduction, was confirmed by different studies on liraglutide and semaglutide
Not affiliated: PlexusDx has no affiliation with LifeMD and no commercial relationship with the companies reviewed in this article